Protective Antibodies Against Clostridium Difficile Are Present in Intravenous Immunoglobulin and Are Retained in Humans Following Its Administration

Clinical and Experimental Immunology - United Kingdom
doi 10.1111/cei.12946
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Mutacin 1140 Lantibiotic Variants Are Efficacious Against Clostridium Difficile Infection

Frontiers in Microbiology
Microbiology
2018English

Infliximab Pharmacokinetics Are Influenced by Intravenous Immunoglobulin Administration in Patients With Kawasaki Disease

Clinical Pharmacokinetics
Pharmacology
2018English

Pharmacokinetics and Metabolism of 14c-Isepamicin in Humans Following Intravenous Administration

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1995English

Immunoglobulin a Antibodies Directed Against Campylobacter Jejuni Flagellin Present in Breast–milk

Epidemiology and Infection
EpidemiologyInfectious Diseases
1994English

Protecting Against Clostridium Difficile Illness

CMAJ
Medicine
2005English

Intraluminal Administration of Resiniferatoxin Protects Against Clostridium Difficile Toxin A-Induced Colitis

Gastroenterology Research and Practice
HepatologyGastroenterology
2017English

Emotionally Expressed Voices Are Retained in Memory Following a Single Exposure

PLoS ONE
Multidisciplinary
2019English

Clostridium Difficile Flagellin FliC: Evaluation as Adjuvant and Use in a Mucosal Vaccine Against Clostridium Difficile

PLoS ONE
Multidisciplinary
2017English

Human Monoclonal Antibodies Directed Against Toxins a and B Prevent Clostridium Difficile-Induced Mortality in Hamsters

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy